News and Comments

ARCA BIOPHARMA: A GENETICALLY TARGETED DRUG FOR ATRIAL FIBRILLATION IN HEART FAILURE PATIENTS

  Thursday, January 09, 2014

A Colorado-based biopharmaceutical company, ARCA Biopharma (ABIO) has a genetically-targeted drug, GencaroTM (bucindolol hydrochloride), for Atrial fibrillation (AF) in patients with heart failure (HF). The drug offers a personalized medicine approach for the treatment of AF in HF, treating only individuals with certain genetic characteristics. This approach enables the selection of individuals who would most probably respond to the drug through excluding the expected non-responders, thus reducing statistically failed trial outcome, in addition to decreasing clinical trial and healthcare costs.    More...


Recent Postings


Archive


Tags

Amgen (AMGN) Anadys (ANDS) Pluristem (PSTI) ISIS (ISIS) Tysabri AstraZeneca (AZN) Sanofi (SNA) Genentech BIOMARIN (BMRN) Ridaforolimus PTC Therapeutics (PTCT) Editas (EDIT) Incyte (INCY) Trastuzumab-DM1 Anacor (ANAC) VANDA (VNDA) NEKTAR (NKTR)) Sanofi-Aventis (SAN) Zerenex SERES THERAPEUTICS (MCRB) ARCA (ABIO) Alnylam (ALNY) SYNTA (SNTA) Intermune (ITMN) Ariad (ARIA) Elan (ELN) Theravance (THRX) Sequenom (SQNM) Xoma (XOMA) Global Cell Therapeutics (GBT) NANTKWEST (NK) KITE (KITE) Sanofi (SNY) Spike Therapeutics (ONCE) Rapamune Valeant Pharmaceuticals International (VRX) Advaxis (ADXS) Array Pharmaceuticals (ARRY) Adaptimmune (ADAP) Roche (RHHBY) Illumina (ILMN) Inovio (INO) GlaxoSmithKline (GSK) Bristol-Myers Squibb (BMY) Biogen Idec (BIIB) Alder Biopharmaceuticals (ALDR) Multiple Myeloma Prolor Biotech (PBTH) Prosensa (RNA) JUNO (JUNO) Sangamo (SGMO) Ionis (IONS) Vitae Pharmaceuticals (VTAE) ADVENTRIX (ANX) Gilead (GILD) Dendreon (DNDN) Mirati Therapeutics (MRTX) Roche (ROCHE) Theravance Bio Pharma (TBPH) Aimmune Therapeutics (AIMT) ACADIA (ACAD) RenenxBio (RGNX) Agenus (AGEN Merck (MRK) Human Genome Sciences (HGSI) CompuGen (CGEN) Agenus (AGEN) MODERNA KERYX (KERX) NOVOCURE (NVCR) AERIE PHARMACEUTICALS AGOS (ARGS) Benlysta (belimumab) Micromet (MITI) Human Longevity (HLI) Seattle Genetics (SGEN) Jazz Pharmaceuticals (JAZZ) Regeneron (REGN) Telaprevir GUARDIAN HEALTH OSI (OSIP) ABBVIE (ABBV) TOKAI (TKAOI) ARGOS (ARGS) Idenix (IDIX) Herceptin C4 Therapeutics Auspex (ASPX) Onyx (ONXX) Abbott Laboratories (ABT) Galena (GALE) ImmunoGen (IMGN) Vertex (VRTX) INNOVIVA (INVA) Endometrial Cancer Dynavax (DVAX) Biocryst (BCRX) Revlimid (lenolidamide) Intercept (ICPT) SUNESIS PHARMACEUTICALS (SNSS) Bellicum (BLCM) Ziofpharm (ZIOP) Intrexon (XON) Exelixis (EXEL) Cytokinetics (CYTK) Sarepta (SRPT) Velcade (bortezomib) IDERA (IDRA) galapagos (GLPG) HALOZYME (HALO) ZALTRAP™ REGULUS (RGLS)